phenylpiperazine has been researched along with 1-(2-methoxyphenyl)piperazine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argentieri, T; Gomez, RP; Lind, JM; Lis, R; Lumma, WC; Morgan, TK; Phillips, GB; Sullivan, ME | 1 |
| el-Ashmawy, MB; Fischer, JB; Glennon, RA; Herndon, JL; Howie, KJ; Ismaiel, AM; Server, AC; Yousif, MY | 1 |
| Baldy, WJ; Davis, CB; DiStefano, DL; Elgin, RJ; Fedde, CL; Kesslick, JM; Martin, GE; Mathiasen, JR; Scott, MK; Shank, RP | 1 |
| Glennon, RA; Lyon, RA; Naiman, NA; Titeler, M | 1 |
| IJzerman, AP; Kruse, CG; Kuipers, W; ter Horst-van Amstel, M; Tulp, MT; van Wijngaarden, I | 1 |
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Abdel-Rahman, AA; Dukat, M; Glennon, RA; Gyermek, L; Ingher, S; Ismaiel, AM; Teitler, M | 1 |
| Beneitez, ME; Benhamú, B; Fuentes, JA; López-Rodríguez, ML; Manzanares, J; Morcillo, MJ; Orensanz, L; Rosado, ML; Sanz, AM | 1 |
| IJzerman, AP; Kruse, CG; Kuipers, W; Spek, AL; Standaar, PJ; Tulp, MT; van Wijngaarden, I; Veldman, N | 1 |
9 other study(ies) available for phenylpiperazine and 1-(2-methoxyphenyl)piperazine
| Article | Year |
|---|---|
Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Binding, Competitive; Dogs; Electric Stimulation; Electrophysiology; Epinephrine; Heart; Molecular Structure; Piperazines; Purkinje Fibers; Receptors, Adrenergic, beta; Sotalol; Structure-Activity Relationship | 1992 |
Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands.
Topics: Animals; Guinea Pigs; In Vitro Techniques; Ligands; Piperazines; Piperidines; Radioligand Assay; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma; Structure-Activity Relationship | 1991 |
Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Dose-Response Relationship, Drug; Piperazines; Rats; Receptors, Dopamine; Receptors, Serotonin; Structure-Activity Relationship | 1989 |
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.
Topics: Animals; Chemical Phenomena; Chemistry; Male; Piperazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Structure-Activity Relationship | 1988 |
N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amino Acid Sequence; Animals; Binding Sites; Chemical Phenomena; Chemistry, Physical; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Piperazines; Protein Conformation; Radioligand Assay; Rats; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship | 1995 |
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
Topics: Animals; Biguanides; Heart Rate; Male; Molecular Structure; Muscle Contraction; Piperazines; Rabbits; Rats; Receptors, Serotonin; Reflex; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Urinary Bladder | 1996 |
Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Body Temperature; Cerebral Cortex; Kinetics; Mice; Piperazines; Raclopride; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Salicylamides; Serotonin Receptor Agonists; Social Behavior; Structure-Activity Relationship | 1996 |
5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; Brain; CHO Cells; Cricetinae; Crystallography, X-Ray; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Piperazines; Protein Binding; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Spiperone; Structure-Activity Relationship | 1997 |